BioSpace News Archive

Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates, today announced that Dr. Behzad Aghazadeh, Executive Chairman, is scheduled to participate in virtual fireside chats at the following healthcare conferences: Jefferies Virtual Healthcare Conference on Thursday, June 4 at 3:30 p.m. Eastern Time Goldman Sachs 41st Annual Global Healthcar

Interim results showed Auxora plus standard of care improved time to recovery and reduced ventilator use in patients compared to standard of care alone

Selected Startups Will Each Receive $150,000 Funding and Access to Expertise from Amazon Web Services, Echo Health Ventures, Express Scripts, and UnitedHealth Group [28-May-2020] SAN FRANCISCO , May 28, 2020 /PRNewswire/ -- The UCSF Rosenman Institute announced today the launch of UCSF Rosenman ADAPT, a competitive program to accelerate the development of health techn

Windtree Therapeutics, Inc. announced it will host a conference call and webcast, including a slide presentation, at 10:00 AM EDT on Thursday, June 4, 2020 to provide Company and business updates, including the recently announced completion of a $23 million public offering and up listing to The Nasdaq Capital Market, as well as updates on its acute cardiovascular and pulmonary clinical programs.

Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Dr. Helen Torley , president and chief executive officer, will be participating in the following investor conferences: Jefferies Virtual Healthcare Conference at 10:00 a.m. ET / 7:00 a.m. PT on Thursday , June 4, 2020 Goldman Sachs 41 st Annual Healthcare Conference a

Lead pipeline investigational compound, SM-88, represents a new approach designed to selectively disrupt cancers metabolic process leading to cancer cell death SM-88 has demonstrated clinical responses in 15 different cancer types across four separate studies TYME-88-Panc pivotal trial enrolling patients using oral SM-88 as a potential treatment for third-line pancreatic cancer PanCAN enrolling patients in its Precision Promise SM adapt

Athira Pharma, Inc., a clinical-stage company dedicated to developing innovative first-in-class regenerative therapies with a lead drug candidate entering Phase 2/3 clinical trials this year for Alzheimer’s disease, today announced that Dr. Leen Kawas, President and Chief Executive Officer, will present at the Jefferies Virtual Global Healthcare Conferenc

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, announced it will host a conference call to review clinical updates and financial results for the three months ended March 31, 2020 on Monday, June 1, 2020 at 8:30 a.m. EDT.

RaySearch Laboratories AB and Varian Medical Systems have entered into an interoperability agreement that will allow the RayCare®* oncology information system to connect to Varian TrueBeam linear accelerators.

The online learning program combines lab simulations and mentoring experiences focused on biotechnology and neurological diseases, such as Parkinson’s disease, Alzheimer’s disease and multiple sclerosis Four hundred students from Massachusetts and North Carolina are enrolling in this no-fee program that also provides students with computers and other technology resources The initiative builds upon Biogen’s Community Lab, which has enrolled more than 55,000 students to date, and the Lemelso